Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.30 |
| ▸ | CA4 | P22748 | 2/20 | 0.30 |
| ▸ | CA5A | P35218 | 2/20 | 0.30 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL7215415 | 1.00 | SLC34A1 (0.58) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL22772184 | 0.95 | SLC34A1 (0.54) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL995486 | 0.95 | SLC34A1 (0.54) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL18894574 | 0.95 | SLC34A1 (0.54) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL8146982 | 0.95 | SLC34A1 (0.54) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL4389858 | 0.95 | SLC34A1 (0.54) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL10951860 | 0.95 | SLC34A1 (0.54) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL6070 | 0.95 | — | — | |
| Phosphoric Acid SCHEMBL8011743 | 0.91 | SLC34A1 (0.50) | SLC34A1LMNAKDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL310374 | 0.91 | SLC34A1 (0.50) | SLC34A1LMNAKDM4ECYP2C19KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3478430-B1 | WASH COMPOSITION FOR MAKING FACINGS ON LOST MOLDS OR ON CORES FOR IRON AND STEEL CASTING OPERATIONS | HUETTENES ALBERTUS CHEMISCHE WERKE GMBH (DE) | 2026-04-08 | — | — | EP | claimed |
| US-12503713-B1 | Stabilization of tryptamines by denaturing enzymes, optimizing ionization states, and controlling confounding variables | Convergent Health Sciences LLC (US) | 2025-12-23 | — | — | US | claimed |
| US-12497637-B1 | Stabilization of tryptamines by denaturing enzymes, optimizing ionization states, and controlling confounding variables | Convergent Health Sciences LLC (US) | 2025-12-16 | — | — | US | claimed |
| US-20240150630-A1 | ADHESIVES FOR FILM LAMINATION AND PRODUCTS MADE THEREFROM | CELANESE INTERNATIONAL CORPORATION (US) | 2024-05-09 | — | — | US | claimed |
| EP-4313593-A1 | ADHESIVES FOR FILM LAMINATION AND PRODUCTS MADE THEREFROM | Celanese International Corporation (US) | 2024-02-07 | — | — | EP | claimed |
| WO-2022204016-A1 | ADHESIVES FOR FILM LAMINATION AND PRODUCTS MADE THEREFROM | CELANESE INTERNATIONAL CORPORATION (US) | 2022-09-29 | — | — | WO | claimed |
| CN-109641261-B | Foundry coating composition for non-permanent molds or cores for iron and steel casting | 胡坦斯·阿尔伯图斯化学厂有限公司 | 2021-06-15 | — | — | CN | claimed |
| US-12611417-B1 | Compositions and methods to inhibit acid-catalyzed dephosphorylation of phosphoryloxytryptamines | Convergent Health Sciences LLC: (US) | 2026-04-28 | — | — | US | disclosed |
| US-12503713-B1 | Stabilization of tryptamines by denaturing enzymes, optimizing ionization states, and controlling confounding variables | Convergent Health Sciences LLC (US) | 2025-12-23 | — | — | US | disclosed |
| US-12497637-B1 | Stabilization of tryptamines by denaturing enzymes, optimizing ionization states, and controlling confounding variables | Convergent Health Sciences LLC (US) | 2025-12-16 | — | — | US | disclosed |
| WO-2025089402-A1 | METHOD FOR MANUFACTURING PHOTOELECTRIC CONVERSION ELEMENT | キヤノン株式会社 | 2025-05-01 | — | — | WO | disclosed |
| WO-2024123788-A1 | ADDUCTS OF POLYAMINO ACIDS, ALKALI METAL PYROPHOSPHATES AND PEROXIDES | ISP INVESTMENTS LLC (US) | 2024-06-13 | — | — | WO | disclosed |
| US-11970438-B2 | Compound, ink, resist composition for color filter, sheet for heat-sensitive transfer recording, and toner | CANON KABUSHIKI KAISHA (JP) | 2024-04-30 | — | — | US | disclosed |
| US-6878712-B1 | Amides as inhibitors for pyruvate dehydrogenase | ASTRAZENECA AB (SE) | 2005-04-12 | — | — | US | disclosed |
| EP-0092256-B1 | PROCESS FOR PREPARING NONIONIC SURFACTANTS BY AN OXYALKYLATION WITH CALCIUM AND/OR STRONTIUM CATALYSTS | UNION CARBIDE CORPORATION (US) | 1986-06-25 | — | — | EP | disclosed |
| EP-0115084-B1 | PROCESS FOR PREPARING NONIONIC SURFACTANTS BY OXYALKYLATION WITH PROMOTED BARIUM CATALYSTS | UNION CARBIDE CORPORATION (US) | 1986-04-23 | — | — | EP | disclosed |
| EP-0115084-A2 | Process for preparing nonionic surfactants by oxyalkylation with promoted barium catalysts | UNION CARBIDE CORPORATION (US) | 1984-08-08 | — | — | EP | disclosed |
| US-4453022-A | REACTING A MONOHYDRIC ALCOHOL WITH AN ALKYLENE OXIDE | UNION CARBIDE CORPORATION (US) | 1984-06-05 | — | — | US | disclosed |
| US-4453023-A | MOLECULAR WEIGHT CONTROL USING A PHOSPHORITE ACID OR PHOSPHATE | UNION CARBIDE CORPORATION (US) | 1984-06-05 | — | — | US | disclosed |
| EP-0092256-A1 | Process for preparing nonionic surfactants by an oxyalkylation with calcium and/or strontium catalysts | UNION CARBIDE CORPORATION (US) | 1983-10-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12611417-B1 | Compositions and methods to inhibit acid-catalyzed dephosphorylation of phosphoryloxytryptamines | PLCB1, PHKG1, PLCB3 | SLC34A1 213/4885LMNA 2508/4885KDM4E 2202/4885 |
| US-11970438-B2 | Compound, ink, resist composition for color filter, sheet for heat-sensitive transfer recording, and toner | C1R, HEATR1, C1S | SLC34A1 1410/4885LMNA 2684/4885KDM4E 2083/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.